A$ 262.14
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Excellent growth
About
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products;...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of PME.AX is 334 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
